Details for Patent: 5,733,569

✉ Email this page to a colleague

Summary for Patent: 5,733,569

Title:	Galenic compositions comprising calcitonin and their use
Abstract:	Pharmaceutical compositions for nasal administration comprising i) a calcitonin, and ii) benzalkonium chloride, and/or iv) a surfactant, suitable for application to the nasal mucosa, in iii) a liquid diluent or carrier, suitable for application to the nasal mucosa. The compositions are suitably adapted for administration in the form of a nasal spray.
Inventor(s):	Azria; Moise (Basel, CH), Cavanak; Thomas (Biel-Benken, CH)
Assignee:	Novartis Corporation (Summit, NJ)
Application Number:	08/471,118
Patent Claim Types: see list of patent claims	Composition; Delivery; Device; Use;

Drugs Protected by US Patent 5,733,569

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,733,569

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	8228390	Oct 05, 1982
Japan	8236928	Dec 30, 1982
United Kingdom	8320865	Aug 03, 1983
United Kingdom	8322528	Aug 22, 1983

International Family Members for US Patent 5,733,569

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	394947	⤷ Sign Up
Austria	402895	⤷ Sign Up
Austria	A259288	⤷ Sign Up
Austria	A349483	⤷ Sign Up
Australia	1984983	⤷ Sign Up
Australia	2103588	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.